Get the Stockscreener App
0.9096
4.43%
0.0386
Ekso Bionics Holdings Inc stock is traded at $0.9096, with a volume of 31,302.
It is up +4.43% in the last 24 hours and down -12.54% over the past month.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
See More
Previous Close:
$0.871
Open:
$0.875
24h Volume:
31,302
Relative Volume:
0.41
Market Cap:
$19.14M
Revenue:
$18.28M
Net Income/Loss:
$-15.20M
P/E Ratio:
-0.7517
EPS:
-1.21
Net Cash Flow:
$-12.21M
1W Performance:
-5.27%
1M Performance:
-12.54%
6M Performance:
-30.56%
1Y Performance:
-22.26%
1-Day Range:
$0.87
$0.91
1-Week Range:
$0.856
$1.00
52-Week Range:
$0.83
$3.1285
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Name
Ekso Bionics Holdings Inc
Sector
Industry
Phone
510-984-1761
Address
101 GLACIER POINT, SAN RAFAEL
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-16 | Initiated | SunTrust | Buy |
Ekso Bionics Holdings Inc Stock (EKSO) Latest News
StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Lake Street Capital Has Lowered Expectations for Ekso Bionics (NASDAQ:EKSO) Stock Price - Defense World
Ekso Bionics Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Ekso Bionics reports lower Q3 sales amid optimism as Medicare reimbursements begin - North Bay Business Journal
H.C. Wainwright cuts Ekso Bionics target by 10%, maintains Buy on growth prospects - Investing.com India
Earnings call: Ekso Bionics announces mixed Q3 results, eyes future growth - Investing.com India
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2024 Earnings Call Transcript - Insider Monkey
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates - MSN
Ekso Bionics Holdings Inc (EKSO) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Ekso Bionics: Q3 Earnings Snapshot - The Advocate
Ekso Bionics Announces Third Quarter 2024 Financial Results - GlobeNewswire
Ekso Bionics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Ekso Bionics Q3 2024 Earnings: EPS Beats Estimates at -$0.10, Re - GuruFocus.com
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com - Defense World
Ekso Bionics (EKSO) to Release Quarterly Earnings on Monday - Defense World
Ekso Bionics Holdings (STU:23E2) Forward Dividend Yield % : 0.00% (As of Oct. 23, 2024) - GuruFocus.com
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024 - The Manila Times
StockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Exoskeleton Market Size to Hit USD 1863.61 Million by 2033 | Straits Research - GlobeNewswire Inc.
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky - GlobeNewswire
Human Augmentation Market Report 2024 Highlighting Rising - openPR
Speech Pathology Services Market Outlook: 2023 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com - Defense World
TNR, The Niche Research says :Global Wearable Robotic Exoskeleton Market is Expected to Expand at a CAGR of 44.3% (2024 to 2034). This Growth Projection Covers Segments Including Type, Application, Functionality, Technology, End User,Region - Yahoo Finance
Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com - Investing.com Canada
Esperion CEO Sheldon Koenig sells shares worth over $26k - Investing.com
BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to an Underperform from a Neutral - Knox Daily
Stock Performance Spotlight: Esperion Therapeutics Inc. (ESPR) Ends the Day at 1.76, Down by -7.85 - The Dwinnex
EMINOVA HOLDINGS INTERNATIONAL signed a 1.5 M USD FUND RAISING AGREEMENT for "BIOREL KIDS FUN FOAM’ product - EIN News
National Bank of Canada FI Raises Stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World
Ekso Bionics (NASDAQ:EKSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Speech Pathology Services Market Outlook: 2022 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Human Augmentation Market 2024 Growth factor – Samsung Electronics Co. Ltd.,Google LLC,Ekso Bionics Holdings Inc.,Garmin Ltd. – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - The Malaysian Reserve
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow
Ekso Bionics Holdings Inc (EKSO) Becoming More Attractive for Investors - Knox Daily
Medical Exoskeleton Market Statistical Forecast, Trade - openPR
SEC Form 424B4 filed by Ekso Bionics Holdings Inc. - Quantisnow
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - ForexTV.com
Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding - Simply Wall St
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update - Yahoo Finance
Ekso Bionics Holdings Inc Stock (EKSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):